Values First Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Values First Advisors, Inc. holds 19 biotech & pharma companies tracked by BioSniper, totaling $15.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$15.5M
| Company | Shares | Value |
|---|---|---|
| EBSEmergent BioSolutions Inc. | 307,880 | $2.6M |
| GHGuardant Health Inc. | 20,765 | $1.9M |
| TECHBIO-TECHNE Corp | 33,699 | $1.8M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 3,246 | $1.1M |
| ELANElanco Animal Health Inc | 44,241 | $1.1M |
| RPRXRoyalty Pharma plc | 20,771 | $996K |
| SRRKScholar Rock Holding Corp | 18,850 | $927K |
| MIRMMirum Pharmaceuticals, Inc. | 9,397 | $868K |
| NEOGNEOGEN CORP | 90,238 | $838K |
| AXSMAxsome Therapeutics, Inc. | 4,587 | $775K |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | 17,086 | $565K |
| BBNXBeta Bionics Inc. | 47,551 | $476K |
| LLYELI LILLY & Co | 426 | $392K |
| PCVXVaxcyte, Inc. | 6,617 | $385K |
| INSMINSMED Inc | 2,203 | $360K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 74,236 | $228K |
| AMGNAMGEN INC | 578 | $203K |
| TLPHTALPHERA, INC. | 81,517 | $61K |
| AGENAGENUS INC | 11,191 | $37K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.